Back

Protalix BioTherapeutics Quote, Financials, Valuation and Earnings

9,530x the last time this happened

Here's what our expert says you should buy before April 14.

Sell

PLX
Protalix BioTherapeutics

Last Price:

1.15

Seasonality Move:

3.5%

7 Day Trial

ALL ACCESS PASS

$ 7

Unlock the Secret to Earning Monthly Income!

Limited spots act swiftly

Protalix BioTherapeutics Price Quote

$1.15

-0.03 (-2.54%)

(Updated: April 26, 2024 at 6:55 PM ET)

Protalix BioTherapeutics Key Stats

Sell

Protalix BioTherapeutics (PLX) is a Sell

Day range:

$1.16 - $1.22

52-week range:

$1.09 - $3.55

Dividend yield:

P/E ratio:

13.11

P/S ratio:

1.40

P/B ratio:

2.57%

Volume:

189.4K

Avg. volume:

399.6K

1-year change:

-52.61%

Market cap:

$86.2M

Revenue:

$65.5M

EPS:

$0.02

How Much Does Protalix BioTherapeutics Make?

How Much Are Protalix BioTherapeutics's Sales Annually?
PLX Revenues are $65.5M
How Much Profit Does Protalix BioTherapeutics's Make A Year?
PLX net income is $8.3M

Is Protalix BioTherapeutics Growing As A Company?

What Is Protalix BioTherapeutics's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.22%
What Is Protalix BioTherapeutics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%

Protalix BioTherapeutics Stock Price Performance

Did Protalix BioTherapeutics Stock Go Up Last Month?
Protalix BioTherapeutics share price went down by -3.28% last month
Did PLX's Share Price Rise Over The Last Year?
PLX share price fell by -52.61% over the past 1 year

What Is Protalix BioTherapeutics 52-Week High & Low?

What Is Protalix BioTherapeutics’s 52-Week High Share Price?
Protalix BioTherapeutics has traded as high as $3.55 over the past 52 weeks
What Is Protalix BioTherapeutics’s 52-Week Low Share Price?
Protalix BioTherapeutics has traded as low as $1.09 over the past 52 weeks

Protalix BioTherapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Protalix BioTherapeutics?

How Much Debt Does Protalix BioTherapeutics Have?
Total long term debt quarterly is $20.3M
How Much Cash Does Protalix BioTherapeutics Have?
Cash and short term investments quarterly total is $44.6M
What Is Protalix BioTherapeutics’s Book Value Per Share?
Book value per share is 0.46

Is Protalix BioTherapeutics Cash Flow Positive?

What Is PLX Cash Flow From Operations?
Cash flow from operations (TTM) is -$1.3M
What Is Protalix BioTherapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $24.7M
What Is Protalix BioTherapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$16.7M

Protalix BioTherapeutics Return On Invested Capital

Is Management Doing A Good Job?
PLX return on invested capital is 19.05%
What Is Protalix BioTherapeutics Return On Assets?
ROA measures how assets are converting to revenues and is 10.86%
What Is PLX Return On Equity?
ROE is a measure of profitability and is 41.07%

Protalix BioTherapeutics Earnings Date & Stock Price

What Is Protalix BioTherapeutics's Stock Price Today?
A single share of PLX can be purchased today for 1.18
What Is Protalix BioTherapeutics’s Stock Symbol?
Protalix BioTherapeutics trades on the nyam under the ticker symbol: PLX
When Is Protalix BioTherapeutics’s Next Earnings Date?
The next quarterly earnings date for Protalix BioTherapeutics is scheduled on May 3, 2024
When Is PLX's next ex-dividend date?
Protalix BioTherapeutics's next ex-dividend date is May 26, 2020
How To Buy Protalix BioTherapeutics Stock?
You can buy Protalix BioTherapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Protalix BioTherapeutics Competitors

Who Are Protalix BioTherapeutics's Competitors?
Below is a list of companies who compete with Protalix BioTherapeutics or are related in some way:
- Agenus Inc (AGEN)
- AIM ImmunoTech Inc (AIM)
- Armata Pharmaceuticals Inc (ARMP)
- Corbus Pharmaceuticals Holdings Inc (CRBP)
- InfuSystems Holdings Inc (INFU)

Protalix BioTherapeutics Dividend Yield